Published in Int J Antimicrob Agents on February 01, 2008
The rising problem of antimicrobial resistance in the intensive care unit. Ann Intensive Care (2011) 1.58
Optical fingerprinting in bacterial epidemiology: Raman spectroscopy as a real-time typing method. J Clin Microbiol (2008) 1.28
Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii. MBio (2013) 1.05
Antibiotic prescription patterns at admission into a tertiary level intensive care unit in Northern India. J Pharm Bioallied Sci (2011) 1.00
Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob Agents Chemother (2012) 0.93
Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us. World J Crit Care Med (2015) 0.87
Implementation of an evidence-based sepsis program in the intensive care unit: evident or not? Crit Care (2009) 0.80
Estimating the length of hospitalization attributable to multidrug antibiotic resistance. Antimicrob Agents Chemother (2010) 0.75
Central Venous Catheter-Related Infection in Severe Trauma Patients. World J Surg (2015) 0.75
A Retrospective Analysis of Direct Medical Cost and Cost of Drug Therapy in Hospitalized Patients at Private Hospital in Western India. J Clin Diagn Res (2015) 0.75
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. Value Health (2007) 3.93
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health (2011) 3.88
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA (2013) 3.78
Systematic review: Effects, design choices, and context of pay-for-performance in health care. BMC Health Serv Res (2010) 2.70
Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis. Lancet Infect Dis (2011) 2.51
Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med (2008) 2.31
Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit Care Med (2003) 2.26
Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis (2005) 2.26
Education in pharmacoeconomics: an international multidisciplinary view. Pharmacoeconomics (2004) 2.25
A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan. Intern Med (2007) 2.17
Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med (2005) 2.16
Quality of life after intensive care: a systematic review of the literature. Crit Care Med (2010) 1.96
Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care (2006) 1.76
Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit. Crit Care Med (2006) 1.71
Discounting health effects in pharmacoeconomic evaluations: current controversies. Pharmacoeconomics (2005) 1.71
Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia. Crit Care Med (2007) 1.66
Intra-abdominal hypertension in patients with severe acute pancreatitis. Crit Care (2005) 1.51
A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients. Diabetes Care (2002) 1.50
Centers for Disease Control and Prevention guidelines for preventing central venous catheter-related infection: results of a knowledge test among 3405 European intensive care nurses. Crit Care Med (2009) 1.48
Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial. BMC Public Health (2013) 1.44
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC Cancer (2013) 1.43
Reduction of catheter related bloodstream infections in intensive care: one for all, all for one? Nurs Crit Care (2009) 1.41
Thinking ahead--the rising tide of AIDS orphans. S Afr Med J (2005) 1.41
Economic evaluations in healthcare: comments on a recent article. Reprod Biomed Online (2005) 1.40
Critical care nursing: towards 2015. Nurs Crit Care (2009) 1.39
Outcome and changes over time in survival following severe burns from 1985 to 2004. Intensive Care Med (2005) 1.33
Outcome in noninvasively and invasively ventilated hematologic patients with acute respiratory failure. Chest (2004) 1.31
Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Crit Care (2008) 1.28
Effect of nosocomial bloodstream infection on the outcome of critically ill patients with acute renal failure treated with renal replacement therapy. J Am Soc Nephrol (2004) 1.25
Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant (2005) 1.18
Outcome of acute kidney injury in severe burns: a systematic review and meta-analysis. Intensive Care Med (2010) 1.17
Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung (2009) 1.14
Cost effectiveness of treatments for wet age-related macular degeneration. Pharmacoeconomics (2011) 1.09
What reimbursement for coronary revascularization with drug-eluting stents? Eur J Health Econ (2004) 1.09
The ties that bind: an integrative framework of physician-hospital alignment. BMC Health Serv Res (2011) 1.08
Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review. Int J Behav Nutr Phys Act (2011) 1.08
Implementation strategies for quality improvement interventions to prevent catheter-related bloodstream infections. Crit Care Med (2014) 1.07
Oral care for mechanically ventilated patients involving toothbrushing. Crit Care Med (2013) 1.04
Cost-effectiveness of 123I-FP-CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy. Mov Disord (2008) 1.03
The impact of disease stage on direct medical costs of HIV management: a review of the international literature. Pharmacoeconomics (2010) 1.02
Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey. Int J Cardiol (2012) 1.02
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial. Br J Ophthalmol (2012) 1.01
De-escalation after empirical meropenem treatment in the intensive care unit: fiction or reality? J Crit Care (2010) 1.01
The impact of the initial ventilatory strategy on survival in hematological patients with acute hypoxemic respiratory failure. J Crit Care (2009) 1.00
Comparison of detailed and succinct cohort modelling approaches in a multi-regional evaluation of cervical cancer vaccination. Vaccine (2008) 0.98
Sodium bicarbonate versus THAM in ICU patients with mild metabolic acidosis. J Nephrol (2005) 0.97
Psychological well-being and socio-economic hardship among AIDS orphans and other vulnerable children in Guinea. AIDS Care (2009) 0.97
Skin replacement in burn wounds. J Trauma (2010) 0.96
Blood stream infections of abdominal origin in the intensive care unit: characteristics and determinants of death. Surg Infect (Larchmt) (2008) 0.96
Adherence to and efficacy and safety of an insulin protocol in the critically ill: a prospective observational study. Am J Crit Care (2007) 0.96
Differential pricing of new pharmaceuticals in lower income European countries. Expert Rev Pharmacoecon Outcomes Res (2013) 0.96
An evaluation of family-centered care services and organization of visiting policies in Belgian intensive care units: a multicenter survey. Heart Lung (2009) 0.94
Perioperative factors determine outcome after surgery for severe acute pancreatitis. Crit Care (2004) 0.94
Vaccination against herpes zoster and postherpetic neuralgia in France: a cost-effectiveness analysis. Expert Rev Pharmacoecon Outcomes Res (2013) 0.94
Reflections on market access for personalized medicine: recommendations for Europe. Value Health (2013) 0.93
Health technology assessments in personalized medicine: illustrations for cost-effectiveness analysis. Expert Rev Pharmacoecon Outcomes Res (2011) 0.92
Epidemiology of infection in critically ill patients with acute renal failure. Crit Care Med (2009) 0.91
Facilitating clinician adherence to guidelines in the intensive care unit. Crit Care Med (2008) 0.91
Pay-for-performance step-by-step: introduction to the MIMIQ model. Health Policy (2010) 0.91
A multi-country economic evaluation of low-dose aspirin in the primary prevention of cardiovascular disease. Pharmacoeconomics (2006) 0.90
No early respiratory benefit with CVVHDF in patients with acute renal failure and acute lung injury. Nephrol Dial Transplant (2002) 0.90
EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristics. Am Heart J (2012) 0.89
Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcome. Intensive Care Med (2005) 0.88
The equity dimension in evaluations of the quality and outcomes framework: a systematic review. BMC Health Serv Res (2011) 0.88
Cost-effectiveness analysis of bicalutamide (Casodex) for adjuvant treatment of early prostate cancer. Value Health (2004) 0.87
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis. Arch Orthop Trauma Surg (2004) 0.87
The cost effectiveness of 123I-FP-CIT SPECT imaging in patients with an uncertain clinical diagnosis of parkinsonism. Eur J Nucl Med Mol Imaging (2008) 0.87
Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study. BMC Infect Dis (2007) 0.86
A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction. Pharmacoeconomics (2006) 0.86
Economic impact of enoxaparin after acute ischemic stroke based on PREVAIL. Clin Appl Thromb Hemost (2010) 0.86
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases. Pharmacoeconomics (2004) 0.85
Voriconazole treatment of invasive aspergillosis: real-world versus health-economic model results. Clin Drug Investig (2008) 0.85
A health economic model to assess the cost-effectiveness of pegylated interferon alpha-2a and ribavirin in patients with moderate chronic hepatitis C and persistently normal alanine aminotransferase levels. Acta Gastroenterol Belg (2007) 0.85
Mechanical ventilation in cancer patients: clinical characteristics and outcomes. Crit Care Clin (2010) 0.85
A cost-effectiveness model of escitalopram, citalopram,and venlafaxine as first-line treatment for major depressive disorder in Belgium. Clin Ther (2005) 0.85
Relative adrenal insufficiency in patients with severe acute pancreatitis. Intensive Care Med (2007) 0.85